FUJIFILM Cellular Dynamics: Human Cells. Endless Possibilities from Discovery to Regenerative Medicine. CDI Notebook
TrendingDigital MediaCDI in the NewsUpcoming EventsApplications
CDI Notebook
Welcome to FCDI Notebook
Trending
Trending: CDI's Company Name and Web Address Have Changed!

CDI's Company Name and Web Address Have Changed! We are now FUJIFILM Cellular Dynamics, Inc. (FCDI), at www.fujifilmcdi.com. These changes further demonstrate a corporate commitment to advancing the utility of iPSCs in discovery, therapeutics, and regenerative medicine research.

WEBSITE >>

Digital Media
Digital Medium: Customer Story - Dr. Kapil Bharti, NIH/NEI

Customer Story: Dr. Kapil Bharti of NIH/NEI. Watch an interview then a data-focused webcast during which Dr. Bharti details the utility of iPSC-derived retinal pigment epithelial cells in disease modeling and researching therapy for age-related macular degeneration (AMD).

INTERVIEW >> | WEBCAST >>

CDI in the News
FCDI in the News: The Next Best Version of Me: How to Live Forever.

The Next Best Version of Me: How to Live Forever. Read how Wired magazine's David Ewing Duncan describes the frontiers of synthetic biology and how FCDI's iPSC technology has a role to play in potential improvements in human health.

ARTICLE >>

Upcoming Events
Upcoming Event: ISSCR 2018

ISSCR 2018 (Jun 20 - 23 | Melbourne, Australia | Booth 97). Join us at our Innovation Showcase, Novel Applications of Human iPSC-derived Neurons: From High-throughput Screening to Patch-seq Analysis, at 11:30 am on Thu, Jun 21, in room 106. Presenters: Anne Bang, PhD, Sanford-Burnham Medical Research Institute; Cedric Bardy, PhD, South Australian Health and Medical Research Institute

PROGRAM >>

Applications
Application: Assessment of Force of Contraction of a Human Induced Pluripotent Stem Cell-derived Cardiomyocyte Cell Line

Assessment of Force of Contraction of a Human Induced Pluripotent Stem Cell-derived Cardiomyocyte Cell Line from a Patient with a β-myosin Heavy Chain 7 (R403Q) Mutation Using the Biowire II 3D Tissue Platform (2018 Keystone Symposia Heart Failure Conference poster). Discover how TARA Biosystems and Regeneron Pharmaceuticals use iCell Cardiomyocytes and MyCell Cardiomyocytes in disease modeling research. Their results show that diseased cardiomyocytes recapitulate clinical features of hypertrophic cardiomyopathy in vitro.

POSTER >>

Follow UsCDI TwitterCDI LinkedInCDI FacebookCDI Youtube

© 2018 FUJIFILM Cellular Dynamics, Inc., 525 Science Drive, Madison, WI 53711
+1 (608) 310-5100 or toll-free (877) 310-6688
fujifilmcdi.com